Top Markets
Coin of the day
Enimmune corporation Enimmune corporation

Enimmune corporation

6564
Clasificación en acciones #26782
Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused... Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused on the research, development, and commercialization of pharmaceutical products. Among its key offerings is Tuberculin PPD RT23 SSI, an approved diagnostic agent utilized in tuberculin tests to ascertain the presence of tuberculosis infection in patients. Beyond its existing products, Enimmune is heavily invested in developing vaccines aimed at combating a diverse array of infectious diseases. These include, but are not limited to, vaccines for enterovirus, pneumonia, norovirus, dengue fever, and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Established in 2014, the company maintains its headquarters in Taichung City, Taiwan.
Precio por acción
$0.52468396
Capitalización bursátil
$37.85M
Cambio (1 día)
1.23%
Cambio (1 año)
-4.53%
País
TW
Comercio Enimmune corporation (6564)

Categoría

Historial del precio de la acción de Enimmune corporation (6564)
Precio más alto de cierre: $0.53 el 2026-08-01

Precio más bajo de cierre: $0.89 el 2018-09-01
Historial del precio de la acción de Enimmune corporation desde 2018 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -7.73%
2025 -21.37%
2024 -30.67%
2023 -42.89%
2022 47.58%
2021 -3.50%
2020 86.97%
2019 -4.98%
2018 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$548.41 39.06%
US
$1.04K 56.84%
NL
$120.74 -14.98%
AU
$140.51 422.52%
US
$761.87 7.04%
CH